Literature DB >> 1618213

Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.

H R Andersen1, L L Knudsen, J M Hasenkam.   

Abstract

A new artificial aortic valve prosthesis was developed for implantation by the transluminal catheter technique without thoracotomy or extracorporal circulation. The new heart valve was prepared by mounting a porcine aortic valve into an expandable stent. Before implantation, the stent-valve was mounted on a balloon catheter and compressed around the deflated balloon. The stent-valve mounted balloon catheter was then advanced retrogradely to the ascending aorta or the aortic root in anaesthetized pigs. Implantation was performed by balloon inflation which expanded the stent-valve to a diameter exceeding the internal diameter of the vessel--thus ensuring a stable fixation against the vessel wall. A total of nine implantations were performed in seven 70 kg closed chest pigs. Sub- and supracoronary implantation was performed in two and three pigs, respectively, while implantation in both positions was done in two. Angiographic and haemodynamic evaluation after implantation revealed no significant stenosis (less than or equal to 16 mmHg) in any of the nine valves and trivial regurgitation in only two. Complications were associated with restriction of the coronary blood flow in three animals. This preliminary study indicates that artificial aortic valves can be implanted in closed chest animals by transluminal catheter technique.

Entities:  

Mesh:

Year:  1992        PMID: 1618213     DOI: 10.1093/oxfordjournals.eurheartj.a060238

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  62 in total

Review 1.  Which strategy for a protein crystallization project?

Authors:  C E Kundrot
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

2.  Surgical approaches to vascular access for large-caliber devices in preclinical research models.

Authors:  Noah Barka; Nancy Rakow; Linnea Lentz; Michael Kopcak; Kent Wika; Ana Menk; Mike Green
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

3.  Need for new materials, biofunctionalization and non-surgical heart valve technology.

Authors:  Jan Sochman
Journal:  World J Cardiol       Date:  2010-03-26

4.  First human case of retrograde transcatheter implantation of an aortic valve prosthesis.

Authors:  David Paniagua; José A Condado; José Besso; Manuel Vélez; Bruno Burger; Salvatore Bibbo; Douglas Cedeno; Harry Acquatella; Carlos Mejia; Eduardo Induni; R David Fish
Journal:  Tex Heart Inst J       Date:  2005

5.  Transarterial aortic valve replacement with a self expanding stent in pigs.

Authors:  M Ferrari; H R Figulla; M Schlosser; I Tenner; I Frerichs; C Damm; V Guyenot; G S Werner; G Hellige
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 6.  Transcatheter aortic valve implantation and mitral valve repair: state of the art.

Authors:  C E Ruiz
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

Review 7.  New percutaneous treatments for valve disease.

Authors:  Louise Coats; Philipp Bonhoeffer
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

Review 8.  Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status.

Authors:  Sameer Arora; Jacob A Misenheimer; Radhakrishnan Ramaraj
Journal:  Tex Heart Inst J       Date:  2017-02-01

9.  Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease.

Authors:  B J M Mulder; R J de Winter; A A M Wilde
Journal:  Neth Heart J       Date:  2007-01       Impact factor: 2.380

Review 10.  Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality.

Authors:  Thomas E Claiborne; Marvin J Slepian; Syed Hossainy; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2012-11       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.